Katherine Watt Chan

Katherine Watt Chan has extensive work experience in the pharmaceutical industry. Katherine Watt is currently the Head of Portfolio and Program Management at Disc Medicine since April 2021. Prior to that, they worked at Novartis Oncology from 2016 to 2021, where they held the position of Senior Global Program Manager. In this role, they managed the Precision Medicine Hematology Development portfolio and led various strategic initiatives related to clinical trial patient screening, regulatory correspondence, and market perspectives.

Before their time at Novartis Oncology, Katherine worked at Novartis Institutes for BioMedical Research (NIBR) from 2003 to 2016. During this period, they served as a Program Manager in the Ophthalmology department and later became the Safety Assessment Expert and Toxicology Laboratory Head. In these roles, they established the Toxicology Laboratory, integrated safety and toxicology data into drug development, and managed toxicology studies in collaboration with internal stakeholders.

Additionally, Katherine had a brief stint at Takeda in 2007, where they worked as a Development Toxicologist. Katherine Watt temporarily left NIBR to contribute to Takeda's preclinical development strategies and collaborated with colleagues in Japan on early-stage oncology projects. Prior to Takeda, they worked as a Toxicologist at Sanofi Genzyme from 2001 to 2003.

Overall, Katherine Watt Chan has a strong background in program management, precision medicine, toxicology, and drug development, with experience in both industry-leading companies and research institutes.

Katherine Watt Chan has a diverse educational background. Katherine Watt holds a Master of Public Health (MPH) degree from Harvard University. Their field of study during their time at Harvard is not specified. Prior to their MPH, Katherine pursued a Doctor of Philosophy (PhD) in Pharmacology and Toxicology at the University of California, Davis. Additionally, they completed a Master of Business Administration (MBA) degree at Boston College.

In terms of certifications, Katherine obtained a certification in "Sheryl Sandberg and Adam Grant on Option B: Building Resilience" from LinkedIn in May 2020. In August 2013, they obtained a Project Management Professional (PMP) certification from the Project Management Institute. Katherine also holds the title of "Diplomate, American Board of Toxicology," but the specific details regarding the institution and year of obtaining the certification are not provided.

Based on the information given, it is evident that Katherine Watt Chan has invested in their education and professional development across various fields, including public health, pharmacology, toxicology, and business administration.